Multiplexed NA Test Simultaneously Detects 15 Respiratory Viruses

A multiplexed nucleic acid (NA) test simultaneously detects 15 respiratory viruses in one hour.

The FilmArray detects viral nucleic acids in nasopharyngeal swabs obtained from individuals suspected of respiratory tract infections. The system represents a significant advancement in user friendliness and multiplex infectious disease testing capability for hospital clinical labs. It requires only two minutes of hands-on time and has a one-hour turnaround time.

The following virus types and subtypes can be tested for using the FilmArray: Adenovirus, Coronavirus HKU1, Coronavirus NL63, Human Metapneumovirus, Influenza A, Influenza A subtype H1, Influenza A subtype H3, Influenza A subtype H1 2009, Influenza B, Parainfluenza virus 1, Parainfluenza virus 2, Parainfluenza virus 3, Parainfluenza virus 4, Rhinovirus/Enterovirus, and Respiratory Syncytial Virus.

Idaho Technology, Inc. (ITI; Salt Lake City, UT, USA) announced that the US Food and Drug Administration (Silver Spring, MD, USA) has issued a 510(k) clearance for its FilmArray instrument and the FilmArray Respiratory Panel.

Idaho Technology, Inc. is a privately held biotechnology company that licensed rapid PCR technology from the University of Utah. The company has additional FilmArray infectious disease applications in its R&D pipeline, including a blood culture ID panel, gastrointestinal panel, and an STI panel.

Related Links:
Idaho Technology
US Food and Drug Administration